Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal testosterone gel for poor ovarian responders undergoing IVF/ICSI
2014-001835-35Phase 3Completed
- Sponsor
- Fundació Santiago Dexeus Font
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in female infertility and poor ovarian response (POR) comparing Androgel with Placebo (2 arms). Primary endpoint: Clinical pregnancy rate. Started Mar 2015; status: completed.
02
Drugs
testosterone
03
Conditions
female infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on 2014-001835-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001835-35.